Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.1B |
| FY2017, ended Dec 31, 2017 | $38.5B |
| FY2018, ended Dec 31, 2018 | $36.5B |
| FY2019, ended Dec 31, 2019 | $53.8B |
| FY2020, ended Dec 31, 2020 | $65.8B |
| FY2021, ended Dec 31, 2021 | $91.7B |
| FY2022, ended Dec 31, 2022 | $61.3B |
| FY2023, ended Dec 31, 2023 | $79.4B |
| FY2024, ended Dec 31, 2024 | $85.4B |
| FY2025, ended Dec 31, 2025 | $80.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $78.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $11.9B |
| FY2017, ended Dec 31, 2017 | $15.0B |
| FY2018, ended Dec 31, 2018 | $17.5B |
| FY2019, ended Dec 31, 2019 | $17.9B |
| FY2020, ended Dec 31, 2020 | $18.4B |
| FY2021, ended Dec 31, 2021 | $19.9B |
| FY2022, ended Dec 31, 2022 | $22.1B |
| FY2023, ended Dec 31, 2023 | $23.1B |
| FY2024, ended Dec 31, 2024 | $23.1B |
| FY2025, ended Dec 31, 2025 | $23.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $24.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.13B | $1.07B |
| FY2017, ended Dec 31, 2017 | $1.73B | $1.66B |
| FY2018, ended Dec 31, 2018 | $1.11B | $1.69B |
| FY2019, ended Dec 31, 2019 | $1.54B | $1.99B |
| FY2020, ended Dec 31, 2020 | $2.03B | $3.10B |
| FY2021, ended Dec 31, 2021 | $1.86B | $1.87B |
| FY2022, ended Dec 31, 2022 | $2.02B | $1.28B |
| FY2023, ended Dec 31, 2023 | $2.39B | $2.63B |
| FY2024, ended Dec 31, 2024 | $2.68B | $2.08B |
| FY2025, ended Dec 31, 2025 | $2.57B | $2.65B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.68B | $3.08B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $890M |
| FY2017, ended Dec 31, 2017 | $204M |
| FY2018, ended Dec 31, 2018 | $156M |
| FY2019, ended Dec 31, 2019 | $162M |
| FY2020, ended Dec 31, 2020 | $227M |
| FY2021, ended Dec 31, 2021 | $166M |
| FY2022, ended Dec 31, 2022 | $199M |
| FY2023, ended Dec 31, 2023 | $277M |
| FY2024, ended Dec 31, 2024 | $210M |
| FY2025, ended Dec 31, 2025 | $207M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $264M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.95B |
| FY2017, ended Dec 31, 2017 | $10.5B |
| FY2018, ended Dec 31, 2018 | $9.34B |
| FY2019, ended Dec 31, 2019 | $8.69B |
| FY2020, ended Dec 31, 2020 | $8.29B |
| FY2021, ended Dec 31, 2021 | $9.62B |
| FY2022, ended Dec 31, 2022 | $10.6B |
| FY2023, ended Dec 31, 2023 | $9.85B |
| FY2024, ended Dec 31, 2024 | $9.89B |
| FY2025, ended Dec 31, 2025 | $10.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $11.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 280M |
| FY2017, ended Dec 31, 2017 | 282M |
| FY2018, ended Dec 31, 2018 | 278M |
| FY2019, ended Dec 31, 2019 | 277M |
| FY2020, ended Dec 31, 2020 | 269M |
| FY2021, ended Dec 31, 2021 | 260M |
| FY2022, ended Dec 31, 2022 | 258M |
| FY2023, ended Dec 31, 2023 | 254M |
| FY2024, ended Dec 31, 2024 | 251M |
| FY2025, ended Dec 31, 2025 | 248M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 242M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees |
|---|---|
| FY2016, ended Dec 31, 2016 | $72.1M |
| FY2017, ended Dec 31, 2017 | $90.3M |
| FY2018, ended Dec 31, 2018 | $82.6M |
| FY2019, ended Dec 31, 2019 | $102M |
| FY2020, ended Dec 31, 2020 | $95.9M |
| FY2021, ended Dec 31, 2021 | $97.7M |
| FY2022, ended Dec 31, 2022 | $99.7M |
| FY2023, ended Dec 31, 2023 | $116M |
| FY2024, ended Dec 31, 2024 | $138M |
| FY2025, ended Dec 31, 2025 | $124M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $117M |
Valuation
At current price- Market Cap
- $78.8B
- P/E
- 29.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.2×
- Price / Book
- 19.8×
- EV / EBITDA
- 18.9×
Growth
Trailing 12 months- Revenue (TTM)
- $24.9B
- Revenue Growth YoY
- 7.0%
- Revenue CAGR 3Y
- 2.1%
- Revenue CAGR 5Y
- 5.1%
- EPS Growth YoY
- 6.2%
- Net Income Growth YoY
- 4.1%
Profitability
Trailing 12 months- Gross Margin
- 48.6%
- Operating Margin
- —
- Net Margin
- 10.7%
- FCF Margin
- 12.4%
- Return on Equity
- 63.7%
Earnings
Trailing 12 months- Net Income
- $2.68B
- EPS (diluted)
- $10.87
- EBITDA
- $4.78B
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $264M
- Total Debt
- $11.8B
- Net Debt
- $11.5B
- Total Assets
- $27.0B
- Total Liabilities
- $23.0B
- Shareholders' Equity
- $3.98B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.68B
- Capital Expenditure
- $606M
- Free Cash Flow
- $3.08B
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $3.19
- Beta (5Y)
- 1.08
Every ratio is calculated from the company’s reported figures.